-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, I05RGg68ni9Yd2NoCcXQ0Ddp4HRvam+eUoGACGXseyElm2MYBkJkP40rBU5hI9S4 OMRZ7e46dUwonrZ0+H0tFQ== 0000902664-09-002088.txt : 20090515 0000902664-09-002088.hdr.sgml : 20090515 20090515161147 ACCESSION NUMBER: 0000902664-09-002088 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090331 FILED AS OF DATE: 20090515 DATE AS OF CHANGE: 20090515 EFFECTIVENESS DATE: 20090515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OSS CAPITAL MANAGEMENT CENTRAL INDEX KEY: 0001218321 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-10371 FILM NUMBER: 09833154 MAIL ADDRESS: STREET 1: 605 THIRD AVE CITY: NEW YORK STATE: NY ZIP: 10158 13F-HR 1 p09-0984form13fhr.txt O.S.S. CAPITAL MANAGEMENT LP UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: March 31, 2009 ---------------------------- Check here if Amendment [ ]; Amendment Number: ----- This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: O.S.S. Capital Management LP -------------------------------------------------- Address: 598 Madison Avenue -------------------------------------------------- New York, NY 10022 -------------------------------------------------- Form 13F File Number: 028-10371 --------- The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Oscar S. Schafer -------------------------------------------------- Title: Senior Managing Member of General Partner -------------------------------------------------- Phone: 212-756-8707 -------------------------------------------------- Signature, Place, and Date of Signing: /s/ Oscar S. Schafer New York, NY 5/15/09 ------------------------ ------------------------------ ---------- [Signature] [City, State] [Date] NOTE: The limited contents of Forms 13F cannot be used as a basis of determining actual or prospective investment performance, and any attempt to use such information may be materially misleading. Report Type (Check only one.): [ x ] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 ------------- Form 13F Information Table Entry Total: 22 ------------- Form 13F Information Table Value Total: $766,406 ------------- (in thousands) List of Other Included Managers: NONE
Form 13F INFORMATION TABLE COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 - -------------------------- ---------------- ----------- ---------- ----------- --- ----- ----------- -------- ----------------- VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE - -------------------------- ---------------- ----------- ---------- ----------- --- ----- ----------- -------- ----- ------ ---- CRYOLIFE INC COM 228903100 5,593 1,079,693 SH SOLE 1,079,693 0 0 ENDO PHARMACEUTICALS HLDGS I COM 29264F205 33,728 1,907,700 SH SOLE 1,907,700 0 0 ENZON PHARMACEUTICALS INC COM 293904108 7,492 1,234,200 SH SOLE 1,234,200 0 0 FIDELITY NATIONAL FINANCIAL CL A 31620R105 82,472 4,227,191 SH SOLE 4,227,191 0 0 FIDELITY NATL INFORMATION SV COM 31620M106 59,597 3,274,549 SH SOLE 3,274,549 0 0 FLAMEL TECHNOLOGIES SA SPONSORED ADR 338488109 37,476 6,246,047 SH SOLE 6,246,047 0 0 ITRON INC COM 465741106 9,915 209,400 SH SOLE 209,400 0 0 LENDER PROCESSING SVCS INC COM 52602E102 129,214 4,221,314 SH SOLE 4,221,314 0 0 MEDIVATION INC COM 58501N101 30,570 1,673,214 SH SOLE 1,673,214 0 0 METAVANTE TECHNOLOGIES INC COM 591407101 45,571 2,283,095 SH SOLE 2,283,095 0 0 NOVEN PHARMACEUTICALS INC COM 670009109 20,355 2,147,147 SH SOLE 2,147,147 0 0 QUALCOMM INC COM 747525103 47,470 1,220,000 SH SOLE 1,220,000 0 0 REGAL ENTMT GROUP CL A 758766109 47,541 3,545,200 SH SOLE 3,545,200 0 0 SALLY BEAUTY HLDGS INC COM 79546E104 19,514 3,435,505 SH SOLE 3,435,505 0 0 SHIRE PLC SPONSORED ADR 82481R106 38,089 1,059,800 SH SOLE 1,059,800 0 0 SMART BALANCE INC COM 83169Y108 18,158 3,006,319 SH SOLE 3,006,319 0 0 TIME WARNER INC COM 887317105 38,265 1,982,665 SH SOLE 1,982,665 0 0 ULURU INC COM 90403T100 2,104 11,687,415 SH SOLE 11,687,415 0 0 VERISIGN INC COM 92343E102 49,859 2,642,251 SH SOLE 2,642,251 0 0 WELLPOINT INC COM 94973V107 9,493 250,000 SH SOLE 250,000 0 0 WYETH COM 983024100 11,190 260,000 SH SOLE 260,000 0 0 WYNDHAM WORLDWIDE CORP COM 98310W108 22,739 5,414,093 SH SOLE 5,414,093 0 0
-----END PRIVACY-ENHANCED MESSAGE-----